27.04.2011 • News

Sun Pharma To Sell Some Merck Diabetes Drugs In India

Sun Pharmaceutical Industries has entered into a deal to market Merck & Co's diabetes drugs - sitagliptin and sitagliptin plus metformin  - in India, the two drugmakers said in a statement on Monday. Under the deal, Sun will have the rights to market the drugs only in India under different brand names, the firms said. Earlier in April, Sun and Merck formed a joint venture to develop and manufacture generic drugs for emerging markets.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.